Renaissance Technologies - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$36,000
-88.9%
27,700
-86.3%
0.00%
Q1 2022$325,000
-27.1%
202,018
-6.2%
0.00%
-100.0%
Q4 2021$446,000
+1043.6%
215,400
+2033.5%
0.00%
Q3 2021$39,000
-96.7%
10,096
-97.3%
0.00%
-100.0%
Q2 2021$1,185,000
+77.9%
370,199
+20.6%
0.00%0.0%
Q1 2021$666,000
+1802.9%
307,000
+1864.5%
0.00%
Q4 2020$35,000
-10.3%
15,627
-22.3%
0.00%
Q1 2020$39,000
-65.2%
20,100
-48.6%
0.00%
Q4 2019$112,000
-22.2%
39,100
+12.6%
0.00%
Q2 2019$144,000
-39.2%
34,732
-6.9%
0.00%
Q2 2018$237,00037,3000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders